Retrospective Analysis of the Incidence of Drug-Induced Interstitial Lung Disease by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Survival in Patients Aged 75 Years or Older with Lung Cancer

INTRODUCTION: To date, the appropriate epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for patients aged ≥75 years with advanced EGFR mutation-positive, nonsmall cell lung cancer remain unknown. METHODS: This study included a total of 89 patients aged ≥75 years who were diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishibashi, Masayuki, Nakagawa, Yoshiko, Shimizu, Tetsuo, Gon, Yasuhiro, Yamamoto, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Medical Association 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169255/
https://www.ncbi.nlm.nih.gov/pubmed/37179737
http://dx.doi.org/10.31662/jmaj.2022-0211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169255/
https://www.ncbi.nlm.nih.gov/pubmed/37179737
http://dx.doi.org/10.31662/jmaj.2022-0211

Ejemplares similares